Genitourinary Cancers | Specialty

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research.

Siteman Cancer Center Houses Broad Research Program

May 15th 2015

Venetoclax Breakthrough Designation, Zarxio Legal Update, and More

May 15th 2015

Dr. Thomas Hutson on Drug Sequencing in Renal Cell Carcinoma

April 24th 2015

Thomas E. Hutson, DO, PharmD, medical oncologist, Director of Genito-Urinary at Texas Oncology–Baylor Charles A. Sammons Cancer Center, discusses drug sequencing for the treatment of renal cell carcinoma.

Cabozantinib in RCC, Cost of Cancer Care, SGR Repeal, and More

April 17th 2015

Dr. Albiges on Implementing mRCC Findings into Practice

April 16th 2015

Laurence Albiges, MD, visiting scientist, Dana-Farber Cancer Institute, discusses how oncologists can treat patients with metastatic renal cell carcinoma (mRCC) based off of findings from a study that looked at the impact of body mass index (BMI) on outcomes of these patients.

The Challenge: Involving Urologists in Cancer Care

April 13th 2015

Management of elevated PSAs, or the next testing equivalent, and prostate cancer should default to the urology world, just like always.

Dr. Balar on Phase III ASSURE Trial Results

March 31st 2015

Arjun V. Balar, MD, oncologist, NYU Langone Medical Center, discusses the results of the phase III ASSURE trial, which compared sorafenib and sunitinib in patients with locally advanced renal cell carcinoma (RCC).

Novel Therapies Needed for Muscle-Invasive Bladder Cancer

March 27th 2015

Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015

Potential Targets in Muscle-Invasive Bladder Cancer

March 27th 2015

Treating Relapsed Muscle-Invasive Bladder Cancer

March 27th 2015

Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015

Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

March 27th 2015

Neoadjuvant and Adjuvant Therapy in Bladder Cancer

March 27th 2015

Managing Renal Pelvis Transitional Cell Carcinoma

March 27th 2015

Lymph Node Dissection in Bladder Cancer

March 27th 2015

Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

March 27th 2015

Advanced Bladder Cancer Increases Suicide Risk, Study Says

March 27th 2015

Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report.

Genetic Testing in RCC

March 26th 2015

Immune Checkpoint Inhibition in RCC

March 26th 2015

NEXT PAGE
PREVIOUS PAGE